Liu C - Search Results

1

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer.

Lombard AP, Liu C, Armstrong CM, D'Abronzo LS, Lou W, Chen H, Dall'Era M, Ghosh PM, Evans CP, Gao AC. Lombard AP, et al. Among authors: liu c. Transl Oncol. 2019 Jul;12(7):871-878. doi: 10.1016/j.tranon.2019.04.007. Epub 2019 May 7. Transl Oncol. 2019. PMID: 31075528 Free PMC article.

2

Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid.

Liu C, Liu H, Li Y, Wu Z, Zhu Y, Wang T, Gao AC, Chen J, Zhou Q. Liu C, et al. Among authors: liu h. Mol Carcinog. 2012 Apr;51(4):303-14. doi: 10.1002/mc.20781. Epub 2011 Apr 22. Mol Carcinog. 2012. PMID: 21520298

3

Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.

Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, Yang J, Evans CP, Zhou Q, Gao AC. Sun M, et al. Among authors: liu c. Prostate. 2012 Jan;72(1):82-9. doi: 10.1002/pros.21409. Epub 2011 May 2. Prostate. 2012. PMID: 21538419 Free PMC article.

4

RhoGDIα suppresses growth and survival of prostate cancer cells.

Zhu Y, Tummala R, Liu C, Nadiminty N, Lou W, Evans CP, Zhou Q, Gao AC. Zhu Y, et al. Among authors: liu c. Prostate. 2012 Mar;72(4):392-8. doi: 10.1002/pros.21441. Epub 2011 Jun 16. Prostate. 2012. PMID: 21681778 Free PMC article.

5

Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.

Liu C, Nadiminty N, Tummala R, Chun JY, Lou W, Zhu Y, Sun M, Evans CP, Zhou Q, Gao AC. Liu C, et al. Genes Cancer. 2011 Feb;2(2):151-9. doi: 10.1177/1947601911409744. Genes Cancer. 2011. PMID: 21779488 Free PMC article.

6

Functional p53 determines docetaxel sensitivity in prostate cancer cells.

Liu C, Zhu Y, Lou W, Nadiminty N, Chen X, Zhou Q, Shi XB, deVere White RW, Gao AC. Liu C, et al. Prostate. 2013 Mar;73(4):418-27. doi: 10.1002/pros.22583. Epub 2012 Sep 19. Prostate. 2013. PMID: 22996738 Free PMC article.

7

NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants.

Nadiminty N, Tummala R, Liu C, Yang J, Lou W, Evans CP, Gao AC. Nadiminty N, et al. Among authors: liu c. Mol Cancer Ther. 2013 Aug;12(8):1629-37. doi: 10.1158/1535-7163.MCT-13-0027. Epub 2013 May 22. Mol Cancer Ther. 2013. PMID: 23699654 Free PMC article.

8

Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer.

Zhu Y, Liu C, Nadiminty N, Lou W, Tummala R, Evans CP, Gao AC. Zhu Y, et al. Among authors: liu c. Mol Cancer Ther. 2013 Sep;12(9):1829-36. doi: 10.1158/1535-7163.MCT-13-0208. Epub 2013 Jul 16. Mol Cancer Ther. 2013. PMID: 23861346 Free PMC article.

9

RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.

Zhu Y, Liu C, Tummala R, Nadiminty N, Lou W, Gao AC. Zhu Y, et al. Among authors: liu c. Prostate. 2013 Nov;73(15):1614-22. doi: 10.1002/pros.22615. Epub 2013 Aug 6. Prostate. 2013. PMID: 23922223 Free PMC article.

10

Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells.

Liu C, Zhu Y, Lou W, Cui Y, Evans CP, Gao AC. Liu C, et al. Prostate. 2014 Feb;74(2):201-9. doi: 10.1002/pros.22741. Epub 2013 Oct 16. Prostate. 2014. PMID: 24307657 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79,630 results

Search Page

Filters